Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicity.

MLA

Ceribelli, Michele, et al. “Multi-Component, Time-Course Screening to Develop Combination Cancer Therapies Based on Synergistic Toxicity.” Proceedings of the National Academy of Sciences of the United States of America, vol. 121, no. 49, Dec. 2024, p. e2413372121. EBSCOhost, https://doi.org/10.1073/pnas.2413372121.

APA

Ceribelli, M., Tosto, F. A., Zhang, X., Melani, C. J., Roschewski, M., Beck, E., Klumpp-Thomas, C., Peer, C. J., Wilson, K. M., Chen, L., McKnight, C., Michael, S., Itkin, Z., Shinn, P., Figg, W. D., Sr, Wilson, W. H., Staudt, L. M., & Thomas, C. J. (2024). Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicity. Proceedings of the National Academy of Sciences of the United States of America, 121(49), e2413372121. https://doi.org/10.1073/pnas.2413372121

Chicago

Ceribelli, Michele, Frances Anne Tosto, Xiaohu Zhang, Christopher J Melani, Mark Roschewski, Erin Beck, Carleen Klumpp-Thomas, et al. 2024. “Multi-Component, Time-Course Screening to Develop Combination Cancer Therapies Based on Synergistic Toxicity.” Proceedings of the National Academy of Sciences of the United States of America 121 (49): e2413372121. doi:10.1073/pnas.2413372121.